Q301--Blood Assays for Alzheimer's 36C24E26Q0040
Summary
AI-generated · Jun 11, 2026Blood assays for Alzheimer's disease are being solicited under a combined synopsis/solicitation; bidders must refer to amendment 0002 for the full requirements and scope of work. The notice in this record does not provide details on deliverables, schedule, or evaluation criteria, so the amendment 0002 package is essential to obtain the official bidding instructions.
Award information is not provided in the excerpt (no award date or amount). Review amendment 0002 for any updated award details and the official procurement terms.
Please see amendment 0002 for information.
From Combined Synopsis/Solicitation posted on Jun 10, 2026Notice history
1-
Combined Synopsis/Solicitation LATEST Posted Jun 10, 2026
Details
Award Information
Documents
7Contacts
Contracting Officer
Phone